Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Krug

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Angewandte Chemie (International Ed. in English)|October 11, 2014
Nanosafety research--are we on the right track?Harald F Krug
Colloids and Surfaces. B, Biointerfaces|August 26, 2018
The uncertainty with nanosafety: Validity and reliability of published dataHarald F Krug
Angewandte Chemie (International Ed. in English)|February 4, 2011
Nanotoxicology: an interdisciplinary challengeHarald F Krug, Peter Wick
Environmental Health Perspectives|September 1, 1994
Effects of organometals on cellular signaling. I. Influence of metabolic inhibitors on metal-induced arachidonic acid liberationA Käfer, H F Krug
Blut|July 1, 1985
Inhibition by pesticides of prostaglandin formation in blood plateletsH F Krug, J Berndt
Molecular Pharmacology|April 1, 1991
Directed shift of fatty acids from phospholipids to triacylglycerols in HL-60 cells induced by nanomolar concentrations of triethyl lead chloride: involvement of a pertussis toxin-sensitive pathwayH F Krug, H Culig
Frontiers in Toxicology|January 2, 2023
Editorial: Methods and protocols in nanotoxicologyHarald F Krug, Katja Nau
Nature: New Biology|December 29, 1971
Glucagon affinity absorbents: selective binding of receptors of liver cell membranesF Krug, B Desbuquois, P Cuatrecasas
Biochimica Et Biophysica Acta|March 20, 1974
Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranesB Desbuquois, F Krug, P Cuatrecasas
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1972
Emergence of insulin receptors on human lymphocytes during in vitro transformationU Krug, F Krug, P Cuatrecasas
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Angewandte Chemie (International Ed. in English)|October 11, 2014
Nanosafety research--are we on the right track?Harald F Krug
Colloids and Surfaces. B, Biointerfaces|August 26, 2018
The uncertainty with nanosafety: Validity and reliability of published dataHarald F Krug
Angewandte Chemie (International Ed. in English)|February 4, 2011
Nanotoxicology: an interdisciplinary challengeHarald F Krug, Peter Wick
Environmental Health Perspectives|September 1, 1994
Effects of organometals on cellular signaling. I. Influence of metabolic inhibitors on metal-induced arachidonic acid liberationA Käfer, H F Krug
Blut|July 1, 1985
Inhibition by pesticides of prostaglandin formation in blood plateletsH F Krug, J Berndt
Molecular Pharmacology|April 1, 1991
Directed shift of fatty acids from phospholipids to triacylglycerols in HL-60 cells induced by nanomolar concentrations of triethyl lead chloride: involvement of a pertussis toxin-sensitive pathwayH F Krug, H Culig
Frontiers in Toxicology|January 2, 2023
Editorial: Methods and protocols in nanotoxicologyHarald F Krug, Katja Nau
Nature: New Biology|December 29, 1971
Glucagon affinity absorbents: selective binding of receptors of liver cell membranesF Krug, B Desbuquois, P Cuatrecasas
Biochimica Et Biophysica Acta|March 20, 1974
Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranesB Desbuquois, F Krug, P Cuatrecasas
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1972
Emergence of insulin receptors on human lymphocytes during in vitro transformationU Krug, F Krug, P Cuatrecasas
Pageof 12